Cagrilintide + Semaglutide is a dual-agonist research pairing that targets complementary pathways in appetite control, energy regulation, and metabolic balance. Cagrilintide, a long-acting amylin analogue,
VIP 10mg
$72.00
HGH Frag 176-191 5mg
$60.00HGH Fragment 176-191 (HGH Frag) is a synthetic peptide consisting of the final 16 amino acids of the human growth hormone (HGH) molecule. Unlike full-length HGH, this truncated fragment does
Thymosin Alpha-1 5mg
$72.00Thymosin Alpha-1 (Tα1) is a naturally occurring 28–amino-acid polypeptide associated with immune regulation and is one of the components found within Thymosin Fraction 5, a crude extract derived from the
Hexarelin 5mg
$42.00Hexarelin is a small synthetic peptide in the growth hormone–releasing peptide (GHRP) family. It is commonly studied for its ability to help the body release more growth hormone, which plays
FOX04-DRI 10mg
$195.00FOXO4-DRI, also known as Proxofim, is a synthetic peptide derived from the forkhead box O transcription factor 4 (FOXO4). FOXO proteins (FOXO1, FOXO3, FOXO4, and FOXO6) regulate essential cellular pathways
L-Glutathione 500mg
$48.00L-Glutathione (GSH) is a tripeptide of glutamate, cysteine, and glycine, widely regarded as a key intracellular antioxidant. It functions as a cofactor for enzymes such as glutathione peroxidase
PEG-MGF 5mg
$60.00PEG-MGF (Pegylated Mechano Growth Factor)
PEG-MGF is a pegylated research peptide derived from Mechano Growth Factor (MGF), an IGF-1 splice variant observed in muscle tissue after mechanical stress in
GHRP-2 10mg
$48.00GHRP-2 (pralmorelin) is a synthetic pentapeptide and growth hormone-releasing peptide (GHRP) that acts as an agonist of the ghrelin (growth hormone secretagogue) receptor, GHS-R1a. Although structurally related to met-enkephalin, GHRP-2
Your Cart Is Still Saved 👀
Don’t lose your saved cart. Enter your email below so your research items are ready whenever you return.
lIMITED tIME rESEARCH aCCESS!
15% Off
Use Code: PURE15
Research Use & Access
Confirmation
Before entering this website, please read and agree
to the following statement:
You are not old enough to view this content.